Ahaan Panday and Aneet Padda starrer Saiyaara, which has turned out to be a phenomenon at the Indian box office, has even surprised fans and experts with its blockbuster response in the international circuits.
It has turned out to be the highest grosser of 2025 for Bollywood in Nepal with 6.62 Crore NPR gross (4.14 CR INR), beating Housefull 5 — 4.92 crore (3.1 cr INR), Sitare Zameen Par — 3.22 crore (2 cr INR) and even Chhaava — 2.20 crore (1.4 cr INR).
It is quite heartening to see a film featuring faces surpassing the business of franchise and big stars in a country due to its emotional storyline and music, which has struck a chord with the audience. Saiyaara is still going super strong in Nepal and is expected to rake in more moolah in the coming days.
Despite not going all out with the promotions, Saiyaara garnered unprecedented excitement among the cinegoers. Before the release of the movie, director Mohit Suri spoke about it and told Firstpost, “I’ve been inside the studio for the last one month. I have no idea. And unlike the past when people travel from one studio to another, this is everything inhouse at YRF. So I haven’t really gone out and met the world outside. Normally, when you are working on other films, you go out for the day; for sound, edit, and VFX. It was different different places.
And just hearing it now, it does feel it does feel very redeeming and validating because when I started off this film, I was quite discouraged by a lot of senior people saying that nobody would be interested in a young love story. Because at that time, larger-than-life films were being made and I just thought that my voice would be lost there when everyone was shouting. So I just went and tried to make a film which is very different from what others were doing. And to me, the fact that people are appreciating that the difference that it’s standing out means a lot.”
A cinephile, who loves, eats and breathes Bollywood and south cinema. Box Office specialist. Obsessed with numbers and trade business of the entertainment industry.